nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—HTR2A—conduct disorder	0.857	1	CbGaD
Trifluoperazine—CALM1—autonomic nervous system—conduct disorder	0.0068	0.245	CbGeAlD
Trifluoperazine—HTR2A—autonomic nervous system—conduct disorder	0.00414	0.149	CbGeAlD
Trifluoperazine—EBPL—brain—conduct disorder	0.00291	0.105	CbGeAlD
Trifluoperazine—CALY—brain—conduct disorder	0.00266	0.0958	CbGeAlD
Trifluoperazine—S100A4—brain—conduct disorder	0.0023	0.0827	CbGeAlD
Trifluoperazine—HTR6—brain—conduct disorder	0.00138	0.0498	CbGeAlD
Trifluoperazine—CALM3—brain—conduct disorder	0.000842	0.0303	CbGeAlD
Trifluoperazine—CHRM2—brain—conduct disorder	0.000829	0.0298	CbGeAlD
Trifluoperazine—HTR2C—brain—conduct disorder	0.000799	0.0288	CbGeAlD
Trifluoperazine—SIGMAR1—brain—conduct disorder	0.000752	0.0271	CbGeAlD
Trifluoperazine—Flupentixol—HTR2A—conduct disorder	0.000729	0.0583	CrCbGaD
Trifluoperazine—HTR1A—brain—conduct disorder	0.000673	0.0242	CbGeAlD
Trifluoperazine—CALM2—brain—conduct disorder	0.000661	0.0238	CbGeAlD
Trifluoperazine—CALM1—brain—conduct disorder	0.000658	0.0237	CbGeAlD
Trifluoperazine—Propiomazine—DRD4—conduct disorder	0.000637	0.051	CrCbGaD
Trifluoperazine—ADRA1A—brain—conduct disorder	0.00062	0.0223	CbGeAlD
Trifluoperazine—DRD2—brain—conduct disorder	0.000608	0.0219	CbGeAlD
Trifluoperazine—Cyamemazine—HTR2A—conduct disorder	0.000571	0.0457	CrCbGaD
Trifluoperazine—Methotrimeprazine—DRD4—conduct disorder	0.000544	0.0436	CrCbGaD
Trifluoperazine—Nefazodone—SLC6A4—conduct disorder	0.00053	0.0424	CrCbGaD
Trifluoperazine—Loxapine—DRD4—conduct disorder	0.000526	0.0421	CrCbGaD
Trifluoperazine—Quetiapine—DRD4—conduct disorder	0.000513	0.0411	CrCbGaD
Trifluoperazine—Trazodone—SLC6A4—conduct disorder	0.00049	0.0392	CrCbGaD
Trifluoperazine—HRH1—brain—conduct disorder	0.00048	0.0173	CbGeAlD
Trifluoperazine—Promazine—DRD4—conduct disorder	0.000472	0.0378	CrCbGaD
Trifluoperazine—Clozapine—DRD4—conduct disorder	0.000441	0.0353	CrCbGaD
Trifluoperazine—Chlorpromazine—DRD4—conduct disorder	0.000415	0.0332	CrCbGaD
Trifluoperazine—Zuclopenthixol—HTR2A—conduct disorder	0.00041	0.0328	CrCbGaD
Trifluoperazine—Nefazodone—HTR2A—conduct disorder	0.000407	0.0326	CrCbGaD
Trifluoperazine—HTR2A—brain—conduct disorder	0.000401	0.0144	CbGeAlD
Trifluoperazine—Trazodone—HTR2A—conduct disorder	0.000377	0.0302	CrCbGaD
Trifluoperazine—Acepromazine—HTR2A—conduct disorder	0.000367	0.0294	CrCbGaD
Trifluoperazine—Clomipramine—SLC6A4—conduct disorder	0.000363	0.0291	CrCbGaD
Trifluoperazine—Thioproperazine—HTR2A—conduct disorder	0.000359	0.0287	CrCbGaD
Trifluoperazine—Pipotiazine—HTR2A—conduct disorder	0.000353	0.0283	CrCbGaD
Trifluoperazine—Thiothixene—HTR2A—conduct disorder	0.000353	0.0283	CrCbGaD
Trifluoperazine—Mesoridazine—HTR2A—conduct disorder	0.000348	0.0279	CrCbGaD
Trifluoperazine—Loxapine—SLC6A4—conduct disorder	0.000315	0.0253	CrCbGaD
Trifluoperazine—Fluphenazine—HTR2A—conduct disorder	0.000305	0.0244	CrCbGaD
Trifluoperazine—Propiomazine—HTR2A—conduct disorder	0.000294	0.0235	CrCbGaD
Trifluoperazine—Clomipramine—HTR2A—conduct disorder	0.000279	0.0223	CrCbGaD
Trifluoperazine—Thioridazine—HTR2A—conduct disorder	0.000263	0.021	CrCbGaD
Trifluoperazine—ABCB1—brain—conduct disorder	0.000263	0.00946	CbGeAlD
Trifluoperazine—Methotrimeprazine—HTR2A—conduct disorder	0.000251	0.0201	CrCbGaD
Trifluoperazine—Promethazine—HTR2A—conduct disorder	0.000247	0.0198	CrCbGaD
Trifluoperazine—Loxapine—HTR2A—conduct disorder	0.000242	0.0194	CrCbGaD
Trifluoperazine—Perphenazine—HTR2A—conduct disorder	0.000241	0.0193	CrCbGaD
Trifluoperazine—Quetiapine—HTR2A—conduct disorder	0.000237	0.0189	CrCbGaD
Trifluoperazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000218	0.00213	CbGpPWpGaD
Trifluoperazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000217	0.00212	CbGpPWpGaD
Trifluoperazine—Promazine—HTR2A—conduct disorder	0.000217	0.0174	CrCbGaD
Trifluoperazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000216	0.00211	CbGpPWpGaD
Trifluoperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000215	0.0021	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000214	0.00209	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000213	0.00209	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—MB21D1—conduct disorder	0.000213	0.00208	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—MB21D1—conduct disorder	0.000213	0.00208	CbGpPWpGaD
Trifluoperazine—HTR2C—G alpha (q) signalling events—HTR2A—conduct disorder	0.000212	0.00207	CbGpPWpGaD
Trifluoperazine—CALM2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—conduct disorder	0.000211	0.00207	CbGpPWpGaD
Trifluoperazine—CALM1—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—conduct disorder	0.000211	0.00207	CbGpPWpGaD
Trifluoperazine—CHRM2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000209	0.00204	CbGpPWpGaD
Trifluoperazine—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.000209	0.00204	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—CGA—conduct disorder	0.000204	0.00199	CbGpPWpGaD
Trifluoperazine—Clozapine—HTR2A—conduct disorder	0.000204	0.0163	CrCbGaD
Trifluoperazine—EBP—Metabolism—COMT—conduct disorder	0.000193	0.00188	CbGpPWpGaD
Trifluoperazine—Chlorpromazine—HTR2A—conduct disorder	0.000191	0.0153	CrCbGaD
Trifluoperazine—EBP—Metabolism—MAOA—conduct disorder	0.000191	0.00187	CbGpPWpGaD
Trifluoperazine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000191	0.00186	CbGpPWpGaD
Trifluoperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00019	0.00185	CbGpPWpGaD
Trifluoperazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000189	0.00185	CbGpPWpGaD
Trifluoperazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000187	0.00182	CbGpPWpGaD
Trifluoperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000186	0.00182	CbGpPWpGaD
Trifluoperazine—EBP—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000185	0.00181	CbGpPWpGaD
Trifluoperazine—HRH1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000184	0.00179	CbGpPWpGaD
Trifluoperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000183	0.00179	CbGpPWpGaD
Trifluoperazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000183	0.00179	CbGpPWpGaD
Trifluoperazine—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.00018	0.00176	CbGpPWpGaD
Trifluoperazine—CALM3—Transmission across Chemical Synapses—COMT—conduct disorder	0.000179	0.00175	CbGpPWpGaD
Trifluoperazine—CALM3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000178	0.00173	CbGpPWpGaD
Trifluoperazine—CALM1—Transmission across Chemical Synapses—COMT—conduct disorder	0.000173	0.00169	CbGpPWpGaD
Trifluoperazine—CALM2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000173	0.00169	CbGpPWpGaD
Trifluoperazine—CALM1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000172	0.00168	CbGpPWpGaD
Trifluoperazine—CALM2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000172	0.00168	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—CGA—conduct disorder	0.000166	0.00162	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—CGA—conduct disorder	0.000165	0.00161	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000165	0.00161	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR ligand binding—DRD4—conduct disorder	0.000165	0.00161	CbGpPWpGaD
Trifluoperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000164	0.0016	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000164	0.0016	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR ligand binding—DRD4—conduct disorder	0.000164	0.0016	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—POLR3A—conduct disorder	0.000162	0.00158	CbGpPWpGaD
Trifluoperazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000161	0.00157	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—POLR3A—conduct disorder	0.000156	0.00153	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—POLR3A—conduct disorder	0.000156	0.00153	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—CGA—conduct disorder	0.000151	0.00147	CbGpPWpGaD
Trifluoperazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00015	0.00147	CbGpPWpGaD
Trifluoperazine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00015	0.00147	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—CGA—conduct disorder	0.00015	0.00147	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.000146	0.00142	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR ligand binding—HTR2A—conduct disorder	0.000145	0.00142	CbGpPWpGaD
Trifluoperazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000145	0.00141	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.000145	0.00141	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—CGA—conduct disorder	0.000144	0.0014	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—CGA—conduct disorder	0.000143	0.0014	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR ligand binding—DRD4—conduct disorder	0.000142	0.00139	CbGpPWpGaD
Trifluoperazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000142	0.00139	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR ligand binding—DRD4—conduct disorder	0.000142	0.00139	CbGpPWpGaD
Trifluoperazine—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000141	0.00138	CbGpPWpGaD
Trifluoperazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000141	0.00138	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—CGA—conduct disorder	0.000141	0.00138	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.000141	0.00137	CbGpPWpGaD
Trifluoperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00014	0.00137	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00014	0.00136	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR ligand binding—DRD4—conduct disorder	0.00014	0.00136	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000139	0.00136	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.000139	0.00136	CbGpPWpGaD
Trifluoperazine—CALM3—Neuronal System—COMT—conduct disorder	0.000137	0.00134	CbGpPWpGaD
Trifluoperazine—CALM3—Neuronal System—MAOA—conduct disorder	0.000136	0.00133	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—WASF1—conduct disorder	0.000136	0.00133	CbGpPWpGaD
Trifluoperazine—CALM2—Neuronal System—COMT—conduct disorder	0.000133	0.00129	CbGpPWpGaD
Trifluoperazine—CALM1—Neuronal System—COMT—conduct disorder	0.000133	0.00129	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—CGA—conduct disorder	0.000132	0.00129	CbGpPWpGaD
Trifluoperazine—CALM1—Neuronal System—MAOA—conduct disorder	0.000132	0.00129	CbGpPWpGaD
Trifluoperazine—CALM2—Neuronal System—MAOA—conduct disorder	0.000132	0.00129	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—WASF1—conduct disorder	0.000132	0.00129	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—WASF1—conduct disorder	0.000132	0.00129	CbGpPWpGaD
Trifluoperazine—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00013	0.00127	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—CGA—conduct disorder	0.00013	0.00127	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—CGA—conduct disorder	0.00013	0.00127	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—MB21D1—conduct disorder	0.000128	0.00125	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—CGA—conduct disorder	0.000128	0.00125	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.000128	0.00125	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR downstream signaling—DRD4—conduct disorder	0.000126	0.00123	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—MB21D1—conduct disorder	0.000124	0.00121	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—MB21D1—conduct disorder	0.000124	0.00121	CbGpPWpGaD
Trifluoperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000124	0.00121	CbGpPWpGaD
Trifluoperazine—CYP1A2—Biological oxidations—COMT—conduct disorder	0.000122	0.00119	CbGpPWpGaD
Trifluoperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000122	0.00119	CbGpPWpGaD
Trifluoperazine—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.000121	0.00118	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CGA—conduct disorder	0.00012	0.00118	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.00012	0.00118	CbGpPWpGaD
Trifluoperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00012	0.00117	CbGpPWpGaD
Trifluoperazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000119	0.00117	CbGpPWpGaD
Trifluoperazine—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000116	0.00113	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—DRD4—conduct disorder	0.000114	0.00111	CbGpPWpGaD
Trifluoperazine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000113	0.0011	CbGpPWpGaD
Trifluoperazine—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000111	0.00108	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—CGA—conduct disorder	0.000108	0.00106	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	0.000107	0.00105	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	0.000107	0.00104	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—CGA—conduct disorder	0.000105	0.00102	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—CGA—conduct disorder	0.000105	0.00102	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000104	0.00101	CbGpPWpGaD
Trifluoperazine—UGT1A4—Metabolism—COMT—conduct disorder	9.92e-05	0.00097	CbGpPWpGaD
Trifluoperazine—XDH—Metabolism—COMT—conduct disorder	9.92e-05	0.00097	CbGpPWpGaD
Trifluoperazine—XDH—Metabolism—MAOA—conduct disorder	9.85e-05	0.000963	CbGpPWpGaD
Trifluoperazine—UGT1A4—Metabolism—MAOA—conduct disorder	9.85e-05	0.000963	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—WASF1—conduct disorder	9.65e-05	0.000943	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	9.43e-05	0.000921	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—POLR3A—conduct disorder	9.41e-05	0.000919	CbGpPWpGaD
Trifluoperazine—DRD2—Circadian rythm related genes—EP300—conduct disorder	9.35e-05	0.000914	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	9.3e-05	0.000909	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	9.26e-05	0.000905	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	9.25e-05	0.000904	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	9.11e-05	0.00089	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—POLR3A—conduct disorder	9.1e-05	0.000889	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—POLR3A—conduct disorder	9.1e-05	0.000889	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	9.09e-05	0.000888	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CGA—conduct disorder	8.91e-05	0.000871	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CGA—conduct disorder	8.87e-05	0.000866	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—DRD4—conduct disorder	8.45e-05	0.000825	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—DRD4—conduct disorder	8.4e-05	0.000821	CbGpPWpGaD
Trifluoperazine—EBP—Metabolism—EP300—conduct disorder	8.26e-05	0.000807	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR downstream signaling—HTR2A—conduct disorder	8.2e-05	0.000801	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	8.17e-05	0.000798	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	8.04e-05	0.000785	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	8.02e-05	0.000783	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—WASF1—conduct disorder	7.92e-05	0.000774	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	7.89e-05	0.000771	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	7.87e-05	0.000769	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CGA—conduct disorder	7.82e-05	0.000764	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CGA—conduct disorder	7.7e-05	0.000752	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CGA—conduct disorder	7.68e-05	0.000751	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—WASF1—conduct disorder	7.66e-05	0.000749	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—WASF1—conduct disorder	7.66e-05	0.000749	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—CGA—conduct disorder	7.64e-05	0.000747	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CGA—conduct disorder	7.56e-05	0.000738	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CGA—conduct disorder	7.54e-05	0.000736	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—HTR2A—conduct disorder	7.45e-05	0.000727	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—DRD4—conduct disorder	7.42e-05	0.000725	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—CGA—conduct disorder	7.39e-05	0.000722	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—CGA—conduct disorder	7.39e-05	0.000722	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	7.3e-05	0.000713	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—DRD4—conduct disorder	7.28e-05	0.000711	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—DRD4—conduct disorder	7.17e-05	0.0007	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	7.15e-05	0.000698	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—WASF1—conduct disorder	7.14e-05	0.000698	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—WASF1—conduct disorder	7.1e-05	0.000694	CbGpPWpGaD
Trifluoperazine—CALM3—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	6.93e-05	0.000677	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—DRD4—conduct disorder	6.74e-05	0.000659	CbGpPWpGaD
Trifluoperazine—CALM2—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	6.7e-05	0.000655	CbGpPWpGaD
Trifluoperazine—CALM1—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	6.7e-05	0.000655	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by WNT in cancer—EP300—conduct disorder	6.43e-05	0.000629	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CGA—conduct disorder	6.39e-05	0.000624	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—WASF1—conduct disorder	6.27e-05	0.000613	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by WNT in cancer—EP300—conduct disorder	6.22e-05	0.000608	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by WNT in cancer—EP300—conduct disorder	6.22e-05	0.000608	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CGA—conduct disorder	6.18e-05	0.000604	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CGA—conduct disorder	6.18e-05	0.000604	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—WASF1—conduct disorder	6.17e-05	0.000603	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—WASF1—conduct disorder	6.16e-05	0.000601	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	6.07e-05	0.000593	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—DRD4—conduct disorder	6.06e-05	0.000592	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—WASF1—conduct disorder	6.06e-05	0.000592	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	6.04e-05	0.00059	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	6.04e-05	0.00059	CbGpPWpGaD
Trifluoperazine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	6.03e-05	0.000589	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—DRD4—conduct disorder	5.86e-05	0.000573	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—DRD4—conduct disorder	5.86e-05	0.000573	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—CGA—conduct disorder	5.79e-05	0.000566	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	5.51e-05	0.000539	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	5.48e-05	0.000536	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	5.33e-05	0.000521	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by Wnt—EP300—conduct disorder	5.3e-05	0.000518	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	5.23e-05	0.000511	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	5.15e-05	0.000503	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	5.13e-05	0.000502	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by Wnt—EP300—conduct disorder	5.13e-05	0.000501	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by Wnt—EP300—conduct disorder	5.13e-05	0.000501	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—WASF1—conduct disorder	5.12e-05	0.0005	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—DRD4—conduct disorder	4.99e-05	0.000488	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—DRD4—conduct disorder	4.96e-05	0.000485	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—WASF1—conduct disorder	4.95e-05	0.000484	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—WASF1—conduct disorder	4.95e-05	0.000484	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	4.84e-05	0.000473	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	4.75e-05	0.000464	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	4.68e-05	0.000457	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	4.66e-05	0.000456	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CGA—conduct disorder	4.62e-05	0.000452	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—HTR2A—conduct disorder	4.4e-05	0.00043	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—DRD4—conduct disorder	4.38e-05	0.000428	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—DRD4—conduct disorder	4.31e-05	0.000421	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—DRD4—conduct disorder	4.3e-05	0.00042	CbGpPWpGaD
Trifluoperazine—UGT1A4—Metabolism—EP300—conduct disorder	4.26e-05	0.000416	CbGpPWpGaD
Trifluoperazine—XDH—Metabolism—EP300—conduct disorder	4.26e-05	0.000416	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—DRD4—conduct disorder	4.23e-05	0.000414	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	4.22e-05	0.000412	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—HTR2A—conduct disorder	3.95e-05	0.000386	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—HTR2A—conduct disorder	3.82e-05	0.000374	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—HTR2A—conduct disorder	3.82e-05	0.000374	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—EP300—conduct disorder	3.65e-05	0.000357	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—DRD4—conduct disorder	3.58e-05	0.00035	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—EP300—conduct disorder	3.53e-05	0.000345	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—EP300—conduct disorder	3.53e-05	0.000345	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—DRD4—conduct disorder	3.46e-05	0.000338	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—DRD4—conduct disorder	3.46e-05	0.000338	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—COMT—conduct disorder	3.45e-05	0.000337	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—MAOA—conduct disorder	3.43e-05	0.000335	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—COMT—conduct disorder	3.34e-05	0.000326	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—COMT—conduct disorder	3.34e-05	0.000326	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—MAOA—conduct disorder	3.31e-05	0.000324	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—MAOA—conduct disorder	3.31e-05	0.000324	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—EP300—conduct disorder	3.29e-05	0.000321	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—HTR2A—conduct disorder	3.26e-05	0.000318	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—HTR2A—conduct disorder	3.24e-05	0.000316	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—EP300—conduct disorder	3.18e-05	0.00031	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—EP300—conduct disorder	3.18e-05	0.00031	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—HTR2A—conduct disorder	2.86e-05	0.000279	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—HTR2A—conduct disorder	2.81e-05	0.000274	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—HTR2A—conduct disorder	2.76e-05	0.00027	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	2.75e-05	0.000269	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—COMT—conduct disorder	2.61e-05	0.000255	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—MAOA—conduct disorder	2.6e-05	0.000254	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—HTR2A—conduct disorder	2.33e-05	0.000228	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—EP300—conduct disorder	2.33e-05	0.000228	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—HTR2A—conduct disorder	2.26e-05	0.000221	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—HTR2A—conduct disorder	2.26e-05	0.000221	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—COMT—conduct disorder	2.09e-05	0.000204	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—MAOA—conduct disorder	2.07e-05	0.000202	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	2.01e-05	0.000196	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—EP300—conduct disorder	1.91e-05	0.000187	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—EP300—conduct disorder	1.85e-05	0.000181	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—EP300—conduct disorder	1.85e-05	0.000181	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—EP300—conduct disorder	1.77e-05	0.000173	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—EP300—conduct disorder	1.72e-05	0.000169	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—EP300—conduct disorder	1.72e-05	0.000168	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—EP300—conduct disorder	1.71e-05	0.000167	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—EP300—conduct disorder	1.71e-05	0.000167	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—EP300—conduct disorder	1.51e-05	0.000148	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—EP300—conduct disorder	1.49e-05	0.000146	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—EP300—conduct disorder	1.49e-05	0.000145	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—EP300—conduct disorder	1.48e-05	0.000145	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—EP300—conduct disorder	1.46e-05	0.000143	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—EP300—conduct disorder	1.46e-05	0.000143	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—EP300—conduct disorder	1.43e-05	0.00014	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—EP300—conduct disorder	1.43e-05	0.00014	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—EP300—conduct disorder	1.24e-05	0.000121	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—EP300—conduct disorder	1.2e-05	0.000117	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—EP300—conduct disorder	1.2e-05	0.000117	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—EP300—conduct disorder	1.12e-05	0.00011	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—EP300—conduct disorder	8.95e-06	8.74e-05	CbGpPWpGaD
